IFF Approves Executive Transaction Incentive Awards & Amends Bylaws
INTERNATIONAL FLAVORS & FRAGRANCES INC
Subscribe to track IFF
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
International Flavors & Fragrances Inc. (NYSE: IFF) - Form 8-K Summary • Item 5.02 (Compensatory Arrangements): Approved one-time equity and cash Transaction Incentive Awards for key executives related to the pending divestiture of the Food Ingredients business. CEO J. Erik Fyrwald was awarded $700,000 in RSUs with 3-year cliff vesting; other named executive officers were awarded cash bonuses ($350k–$700k) payable three months post-close. • Item 5.03 (Bylaw Amendments): Adopted Amended and Restated Bylaws effective October 28, 2026, authorizing virtual/remote-only shareholder meetings and electronic communications. • Trading Significance: Low (standard governance and transaction-retention compensatory updates).
Comprehensive Analysis
Executive Summary
On November 3, 2026, International Flavors & Fragrances Inc. (NYSE: IFF) filed a Current Report on Form 8-K reporting two corporate developments:
- Item 5.02: Approval of one-time Transaction Incentive Awards for executive leadership linked to the successful closing of the sale of its Food Ingredients business.
- Item 5.03: Adoption of Amended and Restated Bylaws to allow virtual/hybrid shareholder meetings.
Item 5.02: Executive Transaction Incentive Awards
On November 2, 2026, the IFF Board of Directors approved transaction incentive awards designed to align executive priorities with the successful closing and transition of the Food Ingredients divestiture (originally announced June 1, 2026).
Key Terms:
- Contingency: Awards are strictly contingent on the closing of the Transaction. If the definitive agreement is terminated, all awards are forfeited.
- Chief Executive Officer (J. Erik Fyrwald): Awarded $700,000 grant date value in Restricted Stock Units (RSUs) under the 2021 Plan, featuring 3-year cliff vesting to align with long-term post-transaction share performance.
- Other Named Executive Officers: Awarded cash bonuses payable in a single lump sum three months following closing, subject to continuous employment through the payment date:
- Michael DeVeau (CFO): $700,000 (Cash)
- Leticia Gonçalves Lourenço (President, Health & Biosciences): $700,000 (Cash)
- Yuvraj Arora (President, Taste & CCO): $350,000 (Cash)
Item 5.03: Amended and Restated Bylaws
Effective October 28, 2026, the Board approved updated Bylaws (Exhibit 3.1) primarily to:
- Authorize shareholder meetings to be held solely by means of remote communication or via hybrid physical/virtual formats.
- Permit modern electronic communications for notice and shareholder participation, consistent with New York Business Corporation Law.
Market & Trading Significance
- Impact: Low.
- Analysis: These compensatory awards represent deal-contingent retention/closing incentives of moderate size (~$2.45 million aggregate across named executive officers), standard for large corporate divestitures. The bylaw revisions are routine governance updates modernizing annual meeting protocols.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.
